Christopher Adams, PharmD, RPh, BCPS

home / authors / christopher-adams-pharmd-rph-bcps

Articles

Implications of the BRIDGE Trial: Should We Forgo Perioperative Anticoagulation?

Implications of the BRIDGE Trial: Should We Forgo Perioperative Anticoagulation?

Christopher Adams, PharmD, RPh, BCPS;Andrea R. Resseguie, PharmD, RPh, CACP
January 18th 2016

Atrial fibrillation is characterized by abnormal impulse formations that cause the heart to beat irregularly.

Read More

A New Direction in Reversal

A New Direction in Reversal

Christopher Adams, PharmD, RPh, BCPS;Andrea R. Resseguie, PharmD, RPh, CACP
August 11th 2015

Target-specific oral anticoagulants dabigatran, rivaroxaban, apixaban, and edoxaban are now being used in a larger and more diverse patient population.

Read More

Latest Updated Articles

AI patient pharmacist provider interactions ASHP summer
Published: June 11th 2024 | Updated: July 27th 2024
Balancing Trust and Technology: The Role of AI in Patient-Pharmacist Interactions
AI pharmacy futures AI disparities skin
Published: June 11th 2024 | Updated: July 27th 2024
Addressing Disparities in AI-Driven Diagnostics: Ethical and Practical Implications
Vice President Kamala Harris -- Image credit: Erin Schaff/Pool/AFP | GETTY | People.com
Published: July 23rd 2024 | Updated: July 27th 2024
VP Kamala Harris’s Policies and Stances on Health Care, Reproductive Rights Take Center Stage
3d illustration of Abstract medical background with Diseased liver - Image credit: Rasi | stock.adobe.com
Published: October 18th 2023 | Updated: July 27th 2024
Pharmacists Can Optimize Treatment for Patients with NASH, Decreasing Economic Burden
Small vial of influenza vaccine.
Published: July 23rd 2024 | Updated: July 27th 2024
Trivalent Influenza Vaccines Are Readied for Fall
Eye Care Pharmacy | Image Credit: I Viewfinder - stock.adobe.com
Published: July 15th 2024 | Updated: July 27th 2024
Biosimilar Ranibizumab Could be More Cost-Effective Than Aflibercept for nAMD